H.‐J. Möller

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

Joost Dekker, David Wood, K.G. Kahl et al. · European Psychiatry · 2009 · 931 citations

Reduced Life Expectancy, Psychological Co-morbidities, Psychiatric Evaluation +22

Accelerated Brain Aging in Schizophrenia and Beyond: A Neuroanatomical Marker of Psychiatric Disorders

Nikolaos Koutsouleris, Christos Davatzikos, Stefan Borgwardt et al. · Schizophrenia Bulletin · 2013 · 473 citations · Full text

Neuropsychology, Aging, Psychiatric Disorders +20

EPA Guidance on Tobacco Dependence and Strategies for Smoking Cessation in People with Mental Illness

Tobias Rüther, Julio Bobes, T.H. Svensson et al. · European Psychiatry · 2014 · 147 citations · Full text

Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol

H.‐J. Möller, P Boyer, O. Fleurot et al. · Psychopharmacology · 1997 · 139 citations

Acute Exacerbations, Psychiatry, Psychotic Disorder +10

Risperidone plasma levels, clinical response and side–effects

Michael Riedel, Markus Schwarz, Martin Strassnig et al. · European Archives of Psychiatry and Clinical Neuroscience · 2004 · 138 citations

Medicine, Psychotropic Medication, Clinical Trials +4